KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Land & Improvements: 2017-2018

Historic Land & Improvements for Alnylam Pharmaceuticals (ALNY) over the last 2 years, with Dec 2018 value amounting to $9.1 million.

  • Alnylam Pharmaceuticals' Land & Improvements changed negligibly% to $9.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $9.1 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $9.1 million for FY2018, which is negligibly% changed negligibly from last year.
  • Alnylam Pharmaceuticals' Land & Improvements amounted to $9.1 million in FY2018, which was down 0.00% from $9.1 million recorded in FY2017.
  • Alnylam Pharmaceuticals' Land & Improvements' 5-year high stood at $9.1 million during FY2017, with a 5-year trough of $9.1 million in FY2017.
  • Over the past 2 years, Alnylam Pharmaceuticals' median Land & Improvements value was $9.1 million (recorded in 2018), while the average stood at $9.1 million.